Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 143   

Articles published

GSK 1,671.10 -3.90 (-0.23%)
price chart
Will Hikma Pharmaceuticals Plc's Stock Price Rise Faster Than GlaxoSmithKline ...
This puts Hikma's stock price performance of the last year ahead of other healthcare stocks such as GlaxoSmithKline plc (LON:GSK) (LSE:GSK.L), AstraZeneca plc (LON:AZN) (LSE:AZN.L), Shire PLC (LON:SHP) (LSE:SHP.L) and Johnson & Johnson ...
Shares of GlaxoSmithKline PLC (GSK) Sees Large Outflow of Money
Shares of GlaxoSmithKline PLC (GSK) traded 0.46 points or 1.12% higher at $41.49.The total intraday money flow for the shares came in at a disappointing $(-6.65) million.
Analyst Reviews on Overbuying: GlaxoSmithKline plc (ADR) (NYSE:GSK)  Post Registrar
GlaxoSmithKline Breaks Above 200-Day Moving Average - Bullish for GSK
In trading on Thursday, shares of GlaxoSmithKline plc (Symbol: GSK) crossed above their 200 day moving average of $41.38, changing hands as high as $41.60 per share.
4 Shares Gaining 3%+ This Week: HSBC Holdings plc, GlaxoSmithKline plc, BHP ...
I haven't found it too tough to get a list together of 4 shares rising over 3% this week. A lot of share prices have risen this week on the back of more positive sentiment from investors toward Donald Trump's economic policy.
Today Analysts Focus on Hess Corporation (HES), GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (NYSE:GSK), maintained return on investment for the last twelve months at 2.93, higher than what Reuters data shows regarding industry's average.
4 Dividend Shares Yielding 4% Or More: Vodafone Group plc, GlaxoSmithKline plc ...
Finding 4 shares with dividend yields over 4% was not particularly difficult. I'm slightly surprised by that, given the prospects for higher inflation this year.
GlaxoSmithKline plc's (GSK) Neutral Rating Reiterated at JPMorgan Chase & Co.
GlaxoSmithKline plc logo JPMorgan Chase & Co. restated their neutral rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note released on Tuesday.
INTERVIEW: Ilika Plc Stereax for bioelectronic implants collaboration through ...
Ilika Plc (LON:IKA) CEO Graeme Purdy talks to DirectorsTalk about a collaboration with Galvani Bioelectronics, the company founded by Alphabet Inc. (NASDAQ:GOOG) subsidiary Verily Life Sciences and British pharmaceutical company GlaxoSmithKline Plc ...
Stock under Brokers Consideration: GlaxoSmithKline plc (GSK)
The stock is currently showing its Return on Assets (ROA) value of 1.6 Percent. The Return on Equity (ROE) and Return on Investment values are 78.6 percent and 8.6 percent respectively.
GlaxoSmithKline's Nucala Positive in Label Expansion Study
GlaxoSmithKline plc. GSK announced that a phase IIIb study evaluating its respiratory drug Nucala (mepolizumab) met all its primary and secondary endpoints.
GlaxoSmithKline (NYSE:GSK) asthma patients, treated with Nucala achieved ...  KC Register